We are live on ! Find out more
EQHA.WS

EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS

Delisted

EQHA.WS was delisted on the 25th of November, 2022.

55 hedge funds and large institutions have $8.6M invested in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

17% more funds holding

Funds holding: 4755 (+8)

15% more capital invested

Capital invested by funds: $7.49M → $8.6M (+$1.11M)

Holders
55
Holders Change
+8
Holders Change %
+17.02%
% of All Funds
0.84%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
7
Reduced
4
Closed
2
Calls
$4.47M
Puts
Net Calls
+$4.47M
Net Calls Change
-$74K

EQHA.WS Hedge Fund Activity: Q4 2021 in Review

55 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) for Q4 2021, worth a combined $8.6M — up 15% from $7.49M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new EQHA.WS positions and 2 closed out — a net gain of 8 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $260K. The largest seller was Monashee Investment Management, exiting entirely with an estimated $29K sold.

  • 55 institutional investors held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) as of Q4 2021, up from 47 in Q3 2021.
  • Funds reported $8.6M of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q4 2021, up 15% quarter-over-quarter.
  • 10 funds opened new EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q4 2021 was Glazer Capital LLC, an estimated $260K added.
  • The largest EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q4 2021 was Monashee Investment Management, an estimated $29K sold.

Based on aggregated 13F filings for Q4 2021.